BDBM380448 4-{3-(Cyanomethyl)-3-[3′-(hydroxymethyl)-1H,1′H-4,4′-bipyrazol-1-yl]azetidin-1-yl}-2,5-difluoro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide trifluoroacetate::US10435392, Example 12::US9926301, Example 12
SMILES: C[C@H](NC(=O)c1cc(F)c(cc1F)N1CC(CC#N)(C1)n1cc(cn1)-c1c[nH]nc1CO)C(F)(F)F
InChI Key:
Data: 4 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
JAK1 (aa 837-1142) (Homo sapiens (Human)) | BDBM380448![]() (4-{3-(Cyanomethyl)-3-[3′-(hydroxymethyl)-1H,...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 650 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi... | US Patent US9926301 (2018) BindingDB Entry DOI: 10.7270/Q2VM4FK3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
JAK2 (aa 828-1132) (Homo sapiens (Human)) | BDBM380448![]() (4-{3-(Cyanomethyl)-3-[3′-(hydroxymethyl)-1H,...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi... | US Patent US10435392 (2019) BindingDB Entry DOI: 10.7270/Q2D50QB7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
JAK1 (aa 837-1142) (Homo sapiens (Human)) | BDBM380448![]() (4-{3-(Cyanomethyl)-3-[3′-(hydroxymethyl)-1H,...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 650 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi... | US Patent US10435392 (2019) BindingDB Entry DOI: 10.7270/Q2D50QB7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
JAK2 (aa 828-1132) (Homo sapiens (Human)) | BDBM380448![]() (4-{3-(Cyanomethyl)-3-[3′-(hydroxymethyl)-1H,...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >700 | n/a | n/a | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description Compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Bi... | US Patent US9926301 (2018) BindingDB Entry DOI: 10.7270/Q2VM4FK3 | |||||||||||
More data for this Ligand-Target Pair |